Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Calvigioni

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Microorganisms|January 23, 2024
Animal and In Vitro Models as Powerful Tools to Decipher the Effects of Enteric Pathogens on the Human Gut MicrobiotaMarco Calvigioni, Diletta Mazzantini, Francesco Celandroni, et al.
Biomolecules|September 27, 2025
<i>In Vitro</i> Analysis of an <i>Alkalihalobacillus clausii</i> Spore-Based Probiotic Formulation Clarifies the Mechanisms Underlying Its Beneficial PropertiesDiletta Mazzantini, Marco Calvigioni, Francesco Celandroni, et al.
Scientific Reports|December 14, 2022
In vitro assessment of probiotic attributes for strains contained in commercial formulationsDiletta Mazzantini, Marco Calvigioni, Francesco Celandroni, et al.
Antimicrobial Agents and Chemotherapy|January 20, 2021
<i>In Vitro</i> Resistance and Evolution of Resistance to Tavaborole in Trichophyton rubrumDiletta Mazzantini, Francesco Celandroni, Marco Calvigioni, et al.
Frontiers in Microbiology|August 6, 2021
Spotlight on the Compositional Quality of Probiotic Formulations Marketed WorldwideDiletta Mazzantini, Marco Calvigioni, Francesco Celandroni, et al.
Microbial Biotechnology|October 22, 2024
Cultivating complexity: Advancements in establishing in vitro models for the mucus-adhering gut microbiotaMarco Calvigioni, Diletta Mazzantini, Francesco Celandroni, et al.
Foods (Basel, Switzerland)|November 27, 2021
Microbiological Quality and Resistance to an Artificial Gut Environment of Two Probiotic FormulationsDiletta Mazzantini, Francesco Celandroni, Marco Calvigioni, et al.
Diabetes/Metabolism Research and Reviews|January 22, 2026
Effect of SGLT2 Inhibitors + DPP-4 Inhibitors on Urine Microbiota in Type 2 DiabetesMarco Calvigioni, Edoardo Biancalana, Chiara Rossi, et al.
Frontiers in Microbiology|May 22, 2020
GTP-Dependent FlhF Homodimer Supports Secretion of a Hemolysin in <i>Bacillus cereus</i>Diletta Mazzantini, Rossella Fonnesu, Francesco Celandroni, et al.
Frontiers in Microbiology|July 18, 2024
Anti-staphylococcal activity of a polyphenol-rich citrus extract: synergy with β-lactams and low proficiency to induce resistanceDiletta Mazzantini, Mariacristina Massimino, Marco Calvigioni, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Microorganisms|January 23, 2024
Animal and In Vitro Models as Powerful Tools to Decipher the Effects of Enteric Pathogens on the Human Gut MicrobiotaMarco Calvigioni, Diletta Mazzantini, Francesco Celandroni, et al.
Biomolecules|September 27, 2025
<i>In Vitro</i> Analysis of an <i>Alkalihalobacillus clausii</i> Spore-Based Probiotic Formulation Clarifies the Mechanisms Underlying Its Beneficial PropertiesDiletta Mazzantini, Marco Calvigioni, Francesco Celandroni, et al.
Scientific Reports|December 14, 2022
In vitro assessment of probiotic attributes for strains contained in commercial formulationsDiletta Mazzantini, Marco Calvigioni, Francesco Celandroni, et al.
Antimicrobial Agents and Chemotherapy|January 20, 2021
<i>In Vitro</i> Resistance and Evolution of Resistance to Tavaborole in Trichophyton rubrumDiletta Mazzantini, Francesco Celandroni, Marco Calvigioni, et al.
Frontiers in Microbiology|August 6, 2021
Spotlight on the Compositional Quality of Probiotic Formulations Marketed WorldwideDiletta Mazzantini, Marco Calvigioni, Francesco Celandroni, et al.
Microbial Biotechnology|October 22, 2024
Cultivating complexity: Advancements in establishing in vitro models for the mucus-adhering gut microbiotaMarco Calvigioni, Diletta Mazzantini, Francesco Celandroni, et al.
Foods (Basel, Switzerland)|November 27, 2021
Microbiological Quality and Resistance to an Artificial Gut Environment of Two Probiotic FormulationsDiletta Mazzantini, Francesco Celandroni, Marco Calvigioni, et al.
Diabetes/Metabolism Research and Reviews|January 22, 2026
Effect of SGLT2 Inhibitors + DPP-4 Inhibitors on Urine Microbiota in Type 2 DiabetesMarco Calvigioni, Edoardo Biancalana, Chiara Rossi, et al.
Frontiers in Microbiology|May 22, 2020
GTP-Dependent FlhF Homodimer Supports Secretion of a Hemolysin in <i>Bacillus cereus</i>Diletta Mazzantini, Rossella Fonnesu, Francesco Celandroni, et al.
Frontiers in Microbiology|July 18, 2024
Anti-staphylococcal activity of a polyphenol-rich citrus extract: synergy with β-lactams and low proficiency to induce resistanceDiletta Mazzantini, Mariacristina Massimino, Marco Calvigioni, et al.
Pageof 3